Forecast: Hospital Discharges for Malignant Neoplasm of Trachea, Bronchus and Lung in Canada

In 2023, the number of hospital discharges for malignant neoplasm of the trachea, bronchus, and lung in Canada was the baseline for forecasted data starting from 2024. The projected trend shows a slight annual decline from 2024 onwards, with values moving from 18.71 thousand in 2024 to 18.43 thousand in 2028, signaling a continued decrease over time.

Year-on-year variations from 2024 to 2028 reflect a consistent downward trend by approximately 0.37% annually. The compound annual growth rate (CAGR) for the period from 2024 to 2028 suggests a gentle decline in discharge rates, showing an average annual decrease in the number of discharges over these years.

Future trends to watch for:

  • Advancements in medical technology and early diagnosis may influence the rate of hospital discharges.
  • Changes in smoking habits and air quality improvements could impact the incidence rates.
  • Healthcare policy alterations could either improve or worsen discharge volume, depending on focus toward prevention or treatment.

Top Countries about Cancer